The Cooper Companies, Inc. (COO) Stock
COO Key Statistics
About The Cooper Companies, Inc.
The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
CEO: Albert G. White. Company website
COO — Frequently Asked Questions
What is the COO stock price today?
The Cooper Companies, Inc. (COO) trades at $62.93, down 1.01% on the day, as of Nov 12, 2026 09:30 UTC.
What is The Cooper Companies, Inc.'s market cap?
The Cooper Companies, Inc. has a market capitalisation of $11.97B, calculated from the live COO share price and shares outstanding.
What is the P/E ratio of COO?
COO trades at a trailing P/E of 21.50, from earnings per share of $2.93 over the last twelve months.
How much revenue does The Cooper Companies, Inc. make?
The Cooper Companies, Inc. generated revenue of $4.24B over the trailing twelve months, which puts the stock at 2.82 times sales.
What is the 52-week range for COO?
COO has traded between $51.01 and $89.83 over the past 52 weeks, and the last price is 29.9% below that high.
Is The Cooper Companies, Inc. profitable?
Yes. The Cooper Companies, Inc. keeps 13.46% of revenue as net income over the trailing twelve months.
What is the analyst price target for COO?
Wall Street analysts rate COO Buy, with an average price target of $65.11, 3.5% above the current price.
What sector is The Cooper Companies, Inc. in?
The Cooper Companies, Inc. is classified under the Healthcare sector and the Medical - Instruments & Supplies industry, and is domiciled in US.
Who is the CEO of The Cooper Companies, Inc.?
Albert G. White is the chief executive of The Cooper Companies, Inc., which employs 15,000 people.
Where can I track COO in real time?
QFI Terminal shows COO with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
See COO live in QFI Terminal
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open COO in Terminal See plans